Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hodgson

Showing results (171-180 of 177) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 177 results.
Vaccine|October 30, 2023
Superior immunogenicity of mRNA over adenoviral vectored COVID-19 vaccines reflects B cell dynamics independent of anti-vector immunity: Implications for future pandemic vaccinesYi Liu, Stephany Sánchez-Ovando, Louise Carolan, et al.
Ecology Letters|December 12, 2018
The diversity of population responses to environmental changeFernando Colchero, Owen R Jones, Dalia A Conde, et al.
Blood Advances|October 2, 2019
Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma AllianceJoshua W D Tobin, Gabrielle Rule, Katherine Colvin, et al.
Blood|September 12, 2025
Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trialEmanuele Zucca, Luca Ceriani, Giovannino Ciccone, et al.
The Lancet. Infectious Diseases|September 14, 2024
Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling studyTimothy W Russell, Hermaleigh Townsley, Joel Hellewell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2024
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial ResultsMaurizio Martelli, Luca Ceriani, Giovannino Ciccone, et al.
The New England Journal of Medicine|October 16, 2024
Nivolumab+AVD in Advanced-Stage Classic Hodgkin's LymphomaAlex F Herrera, Michael LeBlanc, Sharon M Castellino, et al.
Pageof 18

Showing results (171-180 of 177) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 177 results.
Vaccine|October 30, 2023
Superior immunogenicity of mRNA over adenoviral vectored COVID-19 vaccines reflects B cell dynamics independent of anti-vector immunity: Implications for future pandemic vaccinesYi Liu, Stephany Sánchez-Ovando, Louise Carolan, et al.
Ecology Letters|December 12, 2018
The diversity of population responses to environmental changeFernando Colchero, Owen R Jones, Dalia A Conde, et al.
Blood Advances|October 2, 2019
Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma AllianceJoshua W D Tobin, Gabrielle Rule, Katherine Colvin, et al.
Blood|September 12, 2025
Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trialEmanuele Zucca, Luca Ceriani, Giovannino Ciccone, et al.
The Lancet. Infectious Diseases|September 14, 2024
Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling studyTimothy W Russell, Hermaleigh Townsley, Joel Hellewell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2024
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial ResultsMaurizio Martelli, Luca Ceriani, Giovannino Ciccone, et al.
The New England Journal of Medicine|October 16, 2024
Nivolumab+AVD in Advanced-Stage Classic Hodgkin's LymphomaAlex F Herrera, Michael LeBlanc, Sharon M Castellino, et al.
Pageof 18